Randomized clinical trials: Slow death by a thousand unnecessary policies?
Open Access
- 12 October 2004
- journal article
- editorial
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (8), 889-892
- https://doi.org/10.1503/cmaj.1040884
Abstract
Before 1950 the practice of medicine was based largely on observations of outcomes in one individual or in small groups of patients. With the development of the randomized controlled trial (RCT) around the middle of the 20th century, medicine was rapidly transformed, as inferences increasingly wereKeywords
This publication has 12 references indexed in Scilit:
- Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgetsCMAJ : Canadian Medical Association Journal, 2004
- Data protection, informed consent, and researchBMJ, 2004
- Squeezing academic research into a commercial straitjacketBMJ, 2004
- Toward protecting the safety of participants in clinical trialsControlled Clinical Trials, 2003
- Implications of the EU directive on clinical trials for emergency medicineBMJ, 2002
- Randomised controlled trials in cardiovascular medicine: past achievements, future challengesBMJ, 1999
- A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940sBMJ, 1999
- ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.1995
- Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.1986
- Why do we need some large, simple randomized trials?Statistics in Medicine, 1984